Loan Lam
Foot & Ankle Surgery · Tampa, FLNPI 1386866077
Payments from drug & device makers
Across 350 payments — averaging $206.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$52K
- Organogenesis Inc.$9K
- Hartmann USA, Inc.$3K
- Kerecis Limited$2K
- Urgo Medical North America, LLC$1K
- Lifenet Health$1K
- plus $5K from 23 others
What the payments were for
- Consulting fees$5,0857%
- Speaking & faculty fees$36,23350%
- Travel & lodging$20,45528%
- Food & beverage$10,33814%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 128 | $51,584 |
| Organogenesis Inc. | 52 | $8,665 |
| Hartmann USA, Inc. | 8 | $2,684 |
| Kerecis Limited | 5 | $1,693 |
| Urgo Medical North America, LLC | 20 | $1,394 |
| Lifenet Health | 7 | $1,365 |
| ETS Wound Care LLC | 10 | $1,012 |
| Smith+Nephew | 42 | $867 |
| KCI USA, Inc. | 10 | $657 |
| Boston Scientific | 11 | $598 |
| Nuo Therapeutics | 6 | $281 |
| Tactile Systems Technology Inc | 4 | $198 |
| Convatec Inc. | 11 | $179 |
| AbbVie(2 entities) | 8 | $148 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $146 |
| Melinta Therapeutics, LLC | 4 | $87 |
| Reddress USA, Inc. | 1 | $86 |
| Reprise Biomedical, Inc. | 2 | $78 |
| Stryker | 1 | $60 |
| Triad Life Sciences Inc. | 2 | $52 |
| Medline Industries LP | 2 | $51 |
| Bsn Medical Inc | 2 | $44 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Advanced Oxygen Therapy Inc. | 2 | $33 |
| Cashflow Solutions, LLC | 2 | $30 |
| Hydrofera LLC | 1 | $25 |
| Next Science LLC | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $21 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$49,964
- Kerecis Omega3 Marigen$4,862
- Affinity$4,465
- NOVACHOR$4,465
- NuShield$2,765
- ZETUVIT PLUS 10X10 P10$2,450
- Kerecis Omega3 SurgiClose$1,621
- Kerecis Omega3 GraftGuide$1,621
- TheraGenesis Wound Matrix$1,156
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$1,055
- MIRRAGEN ADVANCED WOUND MATRIX$591
- SNAP$526
- Apligraf$363
- Puraply Antimicrobial$302
- GENERAL ATHERECTOMY$279
- PURAPLY WOUND MATRIX$240
- DRAWTEX HYDROCONDUCTIVE WOUND DRESSING WITH LEVAFIBER 4X4$153
- UrgoK2$153
- Dermagraft$123
- Puraply/Affinity/NuTech$123
How this compares
$72,115 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuzyraOmadacycline Tosylate | 37 | $262,880 |
| Pentoxifylline | 101 | $2,510 |
| Duloxetine Hcl | 90 | $1,569 |
| Cefdinir | 41 | $1,132 |
| Linezolid | 15 | $846 |
| Doxycycline Hyclate | 48 | $825 |
| Metronidazole | 14 | $483 |
| Methylprednisolone | 61 | $465 |
| Triamcinolone Acetonide | 11 | $291 |
| Levofloxacin | 41 | $281 |
| Diclofenac Sodium | 11 | $259 |
| Ciprofloxacin Hcl | 14 | $212 |
| Clindamycin Hcl | 14 | $167 |
| Ondansetron Hcl | 16 | $152 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Paratek Pharmaceuticals, Inc.Nuzyra | $51,584 | $262,88037 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Tampa
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.